What to confirm for a recurring hormone program
Inside the Scripts portal, ask for per-vial cost on each hormone formulation you prescribe, since TRT, estradiol, progesterone, and combination products carry different costs. Crucially for a cadence program, confirm rate stability: is your portal rate fixed, or does it renegotiate as Scripts's network contracts change? A rate that drifts upward after you have set patient program pricing erodes margin on a patient base you already committed to. Confirm vial size relative to dosing frequency so your per-dose cost reflects how often patients actually inject or apply, and confirm whether multi-month supply changes the economics.
Because hormone patients are long-horizon, also confirm what happens at contract renewal. If rates can change when Scripts's network pharmacy agreements renegotiate, model the downside so a future increase does not quietly turn a profitable program unprofitable. The recurring nature of TRT and BHRT makes rate predictability a first-class concern, not a footnote.